Profusa, Inc.

Profusa, Inc. (PFSA) is a medical technology company focused on implantable continuous biosensor systems designed to monitor body chemistry in real time, with applications spanning clinical diagnostics, military health monitoring, and consumer wellness. The company filed a Form 10-Q with the Securities and Exchange Commission on November 10, 2022, under accession number 0001213900-22-071284, covering quarterly financial results and reflecting its ongoing reporting obligations as a publicly traded entity within the digital health and medical device sector. Profusa's continuous sensing platform positions it at the intersection of biotechnology and wearables innovation. Sign up on SpacDesk for full filing history, financial data, and SPAC transaction details on Profusa and the broader SPAC market.